Mira Pharmaceuticals (MIRA) Cash from Operations (2022 - 2025)
Mira Pharmaceuticals (MIRA) posted Cash from Operations of 1173368.0 for Q4 2025, down 4.15% sequentially from 1126632.0 in Q3 2025, and up 34.99% YoY from 869196.62 in Q4 2024.
Mira Pharmaceuticals (MIRA) Cash from Operations (2022 - 2025) Analysis & Trends
Mira Pharmaceuticals (MIRA) has 4 years of Cash from Operations data on file, last reported at 1173368.0 in Q4 2025.
- Quarterly Cash from Operations rose 34.99% year-over-year to 1173368.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 4700000.0 (up 15.48% YoY) and the FY2025 annual result came in at 4700000.0, up 15.48% from the prior year.
- Cash from Operations fell to 1173368.0 in Q4 2025 per MIRA's latest filing, from 1126632.0 in the prior quarter.
- The five-year high for Cash from Operations was 660813.0 in Q2 2023, with the low at 1842111.0 in Q3 2024.
- Average Cash from Operations over 4 years is 1220245.36, with a median of 1100969.0 recorded in 2023.
- Year-over-year, Cash from Operations slumped 74.4% in 2024 and surged 38.84% in 2025.
- Mira Pharmaceuticals' Cash from Operations stood at 975436.0 in 2022, then dropped by 6.11% to 1035015.0 in 2023, then tumbled by 74.4% to 1805030.0 in 2024, then soared by 34.99% to 1173368.0 in 2025.
- Business Quant data shows MIRA's Cash from Operations at 1173368.0 in Q4 2025, 1126632.0 in Q3 2025, and 800000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 5.33 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 2.51 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 3.83 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 3.92 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 2.19 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 2.54 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.62 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Mira Pharmaceuticals | 22.51 Mn | 11.48 Mn | - | -1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.17 Mn |
| Dec 31, 2025 | -1.17 Mn |
| Sep 30, 2025 | -1.13 Mn |
| Sep 30, 2025 | -1.13 Mn |
| Jun 30, 2025 | -800,000.00 |
| Jun 30, 2025 | -800,000.00 |
| Mar 31, 2025 | -1.60 Mn |
| Mar 31, 2025 | -1.60 Mn |
| Dec 31, 2024 | -1.81 Mn |
| Dec 31, 2024 | -1.81 Mn |
| Sep 30, 2024 | -1.84 Mn |
| Sep 30, 2024 | -1.84 Mn |
| Jun 30, 2024 | -863,929.00 |
| Jun 30, 2024 | -863,929.00 |
| Mar 31, 2024 | -1.05 Mn |
| Mar 31, 2024 | -1.05 Mn |
| Dec 31, 2023 | -1.04 Mn |
| Dec 31, 2023 | -1.04 Mn |
| Sep 30, 2023 | -1.76 Mn |
| Sep 30, 2023 | -1.76 Mn |